Paper2647
Multiple sedimenting species of properdin in human serum and interaction of purified properdin with the third component of complement.
Chapitis J and 1 other. J Exp Med, 1976. Cited by 40 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Multiple sedimenting species of properdin in human serum and interaction of purified properdin with the third component of complement. Papers, record 2647. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2647
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Multiple sedimenting species of properdin in human serum and interaction of purified properdin with the third component of complement.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Complement C3 | Major topic |
| Complement System Proteins | Major topic |
| Properdin | Major topic |
| ABO Blood-Group System | |
| Humans | |
| Hydrogen-Ion Concentration | |
| Lipodystrophy | |
| Temperature | |
| Ultracentrifugation |
Source PubMed
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1,165,475 | Properdin- and nephritic factor-dependent C3 convertases: requirement of native C3 for enzyme formation and the function of bound C3b as properdin receptor. | J Exp Med | 1975 | https://conductscience.org/library/papers/1165475 | PubMed |
| 2 | 6,019,133 | Formation and functional significance of a molecular complex derived from the second and the fourth component of human complement. | J Exp Med | 1967 | https://conductscience.org/library/papers/6019133 | PubMed |
| 3 | 123,262 | Changes in the immunochemical properties of highly purified properdin in human serum. | J Immunol | 1975 | https://conductscience.org/library/papers/123262 | PubMed |
| 4 | 13,713,200 | High specific activity iodination of gamma-globulin with iodine-131 monochloride. | Cancer Res | 1960 | https://conductscience.org/library/papers/13713200 | PubMed |
| 5 | 13,767,412 | A method for determining the sedimentation behavior of enzymes: application to protein mixtures. | J Biol Chem | 1961 | https://conductscience.org/library/papers/13767412 | PubMed |
| 6 | 14,151,101 | THE MACROMOLECULAR NATURE OF THE FIRST COMPONENT OF HUMAN COMPLEMENT. | J Exp Med | 1964 | https://conductscience.org/library/papers/14151101 | PubMed |
| 7 | 14,316,946 | ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT. | J Exp Med | 1965 | https://conductscience.org/library/papers/14316946 | PubMed |
| 8 | 14,415,902 | The properdin system and immunity. X. Characterization of partially purified human properdin. | J Immunol | 1959 | https://conductscience.org/library/papers/14415902 | PubMed |
| 10 | 4,117,597 | Homozygous deficiency of C3 in a patient with repeated infections. | Lancet | 1972 | https://conductscience.org/library/papers/4117597 | PubMed |
| 11 | 4,165,629 | Studies on the mode of action of the fifth, sixth and seventh component of human complement in immune haemolysis. | Immunology | 1967 | https://conductscience.org/library/papers/4165629 | PubMed |
| 12 | 4,166,243 | Immune hemolysis: a simplified method for the preparation of EAC'4 with guinea pig or with human complement. | J Immunol | 1967 | https://conductscience.org/library/papers/4166243 | PubMed |
| 13 | 4,169,693 | Properties of highly purified human properdin. | J Immunol | 1968 | https://conductscience.org/library/papers/4169693 | PubMed |
| 14 | 4,213,402 | Studies of complement complex C5b,6 eluted from--EAC-6: reaction of C5b,6 with EAC4b,3b and evidence on the role of C2a and C3b in the activation of C5. | J Immunol | 1974 | https://conductscience.org/library/papers/4213402 | PubMed |
| 15 | 4,477,550 | Studies on the sub-unit structure of human properdin. | Immunochemistry | 1974 | https://conductscience.org/library/papers/4477550 | PubMed |
| 16 | 4,555,693 | Observations on the effects of a proteinase from Serratia marcescens on the third component of human complement. | Am J Med Sci | 1972 | https://conductscience.org/library/papers/4555693 | PubMed |
| 17 | 4,719,679 | The membrane attack mechanism of complement. Verification of a stable C5-9 complex in free solution. | J Exp Med | 1973 | https://conductscience.org/library/papers/4719679 | PubMed |
| 18 | 4,737,061 | The membrane attack mechanism of complement. Reversible interactions among the five native components in free solution. | J Exp Med | 1973 | https://conductscience.org/library/papers/4737061 | PubMed |
| 19 | 4,738,906 | Solid phase radioimmunoassay of properdin. | Immunochemistry | 1973 | https://conductscience.org/library/papers/4738906 | PubMed |
| 20 | 47,885 | The membrane attack mechanism of complement. Isolation and subunit composition of the C5b-9 complex. | J Exp Med | 1975 | https://conductscience.org/library/papers/47885 | PubMed |
| 21 | 4,831,630 | Computer stimulation of sedimentation in the ultracentrifuge. VII. Solutes undergoing indefinite self-association. | Arch Biochem Biophys | 1974 | https://conductscience.org/library/papers/4831630 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 32,485,958 | A New Era in Endothelial Injury Syndromes: Toxicity of CAR-T Cells and the Role of Immunity. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32485958 | PubMed |
| 32,310,222 | Complementopathies and precision medicine. | J Clin Invest | 2020 | https://conductscience.org/library/papers/32310222 | PubMed |
| 29,167,939 | The properdin pathway: an "alternative activation pathway" or a "critical amplification loop" for C3 and C5 activation? | Semin Immunopathol | 2018 | https://conductscience.org/library/papers/29167939 | PubMed |
| 26,043,382 | Complement: an overview for the clinician. | Hematol Oncol Clin North Am | 2015 | https://conductscience.org/library/papers/26043382 | PubMed |
| 8,288,944 | Properdin: approaching four decades of research. | Immunol Res | 1993 | https://conductscience.org/library/papers/8288944 | PubMed |
| 6,696,726 | Mapping of the properdin-binding site in the third component of complement. | Biochem J | 1984 | https://conductscience.org/library/papers/6696726 | PubMed |
| 6,418,767 | Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum. | J Clin Invest | 1984 | https://conductscience.org/library/papers/6418767 | PubMed |
| 3,421,908 | Analysis of the interactions between properdin, the third component of complement (C3), and its physiological activation products. | Biochem J | 1988 | https://conductscience.org/library/papers/3421908 | PubMed |
| 3,307,764 | Resolution and analysis of 'native' and 'activated' properdin. | Biochem J | 1987 | https://conductscience.org/library/papers/3307764 | PubMed |
| 3,140,783 | Analysis of the interaction between properdin and factor B, components of the alternative-pathway C3 convertase of complement. | Biochem J | 1988 | https://conductscience.org/library/papers/3140783 | PubMed |
| 1,067,618 | Control of the amplification convertase of complement by the plasma protein beta1H. | Proc Natl Acad Sci U S A | 1976 | https://conductscience.org/library/papers/1067618 | PubMed |
| 978,134 | Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway. | J Exp Med | 1976 | https://conductscience.org/library/papers/978134 | PubMed |
| 871,825 | Cryoglobulinaemia in Henoch-Schönlein purpura. | Br Med J | 1977 | https://conductscience.org/library/papers/871825 | PubMed |
| 830,792 | Requirements for the solubilization of immune aggregates by complement: assembly of a factor B-dependent C3-convertase on the immune complexes. | J Exp Med | 1977 | https://conductscience.org/library/papers/830792 | PubMed |
| 670,397 | Requirements for the solubilization of immune aggregates by complement. The role of the classical pathway. | J Clin Invest | 1978 | https://conductscience.org/library/papers/670397 | PubMed |
| 559,720 | Activation of the alternative complement pathway with rabbit erythrocytes by circumvention of the regulatory action of endogenous control proteins. | J Exp Med | 1977 | https://conductscience.org/library/papers/559720 | PubMed |
| 273,923 | Regulation by membrane sialic acid of beta1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway. | Proc Natl Acad Sci U S A | 1978 | https://conductscience.org/library/papers/273923 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| C3 | 718 | PubTator's text mining | https://conductscience.org/library/genes/718 | NCBI Gene |
| CFP | 5,199 | PubTator's text mining | https://conductscience.org/library/genes/5199 | NCBI Gene |
| ERVK-3 | 100,862,689 | PubTator's text mining | https://conductscience.org/library/genes/100862689 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2647
GET https://conductscience.org/api/papers/v1/2647/references?page=2